ulcerative colitis

New TREMFYA Data Show an Overall Clinical Response Rate of Approximately 80 Percent in a Phase 2b Induction Study of Adults with Moderately to Severely Active Ulcerative Colitis
Marketscreener
Tue, 10/25/22 - 10:53 am
JNJ
Janssen
clinical trials
ulcerative colitis
Tremfya
Palatin enrols first subject in Phase II ulcerative colitis therapy trial
Clinical Trials Arena
Fri, 10/21/22 - 10:41 am
Palatin Technologies
ulcerative colitis
PL8177
clinical trials
Janssen Touts Positive Mid-Late Stage Data From Two Ulcerative Colitis Trials
BioSpace
Mon, 10/10/22 - 10:52 am
JNJ
Janssen
ulcerative colitis
guselkumab
golimumab
Pfizer, Gilead and others seek clarifications on trial designs outlined in FDA's UC and Crohn's draft guidance
Endpoints
Thu, 07/21/22 - 10:38 am
Pfizer
Gilead Sciences
Big Pharma
ulcerative colitis
Crohn's Disease
drug development
FDA
Why This Promising Drug Will Be Pfizer's Next Blockbuster
Motley Fool
Sun, 07/10/22 - 11:53 pm
Pfizer
etrasimod
ulcerative colitis
This Blockbuster Drug from AbbVie Is Closer to Another Major Indication
Motley Fool
Tue, 07/5/22 - 11:05 am
Rinvoq
AbbVie
Europe
ulcerative colitis
AbbVie Redeems Priority Review Voucher for Rinvoq Approval
BioSpace
Thu, 06/23/22 - 07:53 pm
AbbVie
Rinvoq
priority review
priority review vouchers
ulcerative colitis
After ulcerative colitis flop, Immunic regains some momentum with multiple sclerosis update
Fierce Biotech
Wed, 06/15/22 - 10:58 am
Immunic
MS
multiple sclerosis
ulcerative colitis
vidofludimus calcium
Immunic says its colitis failure won’t hamper MS program
BioWorld
Sun, 06/5/22 - 11:28 pm
Immunic
vidofludimus calcium
ulcerative colitis
Pfizer ulcerative colitis drug leads to remission in a third of patients -study
Reuters
Tue, 05/24/22 - 04:43 pm
Pfizer
ulcerative colitis
etrasimod
clinical trials
Second trial opens door for Lilly’s mirikizumab in ulcerative colitis
Pharmaforum
Tue, 05/24/22 - 10:45 am
Eli Lilly
clinical trials
ulcerative colitis
mirikizumab
Exclusive: Connect Biopharma reports a PhII fail for Zeposia challenger, and execs appear ready to punt
Endpoints
Tue, 05/3/22 - 10:46 pm
Connect Biopharma
Pfizer
Bristol Myers Squibb
FDA
clinical trials
ulcerative colitis
CBP-307
FDA guidance machine churns out 8 new documents in less than a week
Endpoints
Mon, 05/2/22 - 06:17 pm
FDA
regulatory
ulcerative colitis
Crohn's Disease
cancer
clinical trials
Xbiome acquires live biotherapeutic product program targeting ulcerative colitis
Biopharma Reporter
Thu, 04/28/22 - 10:39 pm
Xbiome
microbiome
hepatitis B
artificial intelligence
ulcerative colitis
Not IDEAL: Protagonist sinks as high dose of oral Entyvio rival fails in ulcerative colitis
Fierce Biotech
Tue, 04/26/22 - 10:16 am
Protagonist Therapeutics
clinical trials
ulcerative colitis
Entyvio
Phase 2 deja vu for gossamer bio after ulcerative colitis med flops
Fierce Biotech
Mon, 04/25/22 - 10:37 pm
Gossamer Bio
ulcerative colitis
clinical trials
GB004
Pfizer's $6.7 Billion Bet Could Be About to Pay Off Big Time
Motley Fool
Wed, 04/6/22 - 11:52 am
Pfizer
M&A
Arena Pharmaceuticals
etrasimod
clinical trials
ulcerative colitis
Protagonist seeks an Ideal readout
EP Vantage
Wed, 04/6/22 - 11:37 am
Protagonist Therapeutics
PN-943
clinical trials
ulcerative colitis
Pfizer's $7B ulcerative colitis drug racks up another phase 3 win, laying the groundwork for approval filings
Fierce Biotech
Tue, 03/29/22 - 10:50 am
Pfizer
ulcerative colitis
etrasimod
Arena Pharmaceuticals
clinical trials
Pfizer Lining Up New UC Drug, Former Employees Launch Counter Suit
BioSpace
Wed, 03/23/22 - 10:56 pm
Pfizer
ulcerative colitis
Xeljanz

Pages